Skip to main content

Urology · UK

TURBT - bladder tumour resection, diagnosis and treatment in one visit.

A rigid cystoscope passed through the urethra, the visible tumour resected with a loop, muscle taken for staging, and single-shot chemotherapy instilled before you wake up. Consultant urology-led, with blue light where indicated and a same-week histology plan.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What a private TURBT costs in the UK.

Indicative ranges across our partner units.

In short

£4,500–£7,500, home same day or next morning.

Procedure Indicative range
TURBT, day-case £4,500–£7,500
TURBT with one night stay £5,500–£9,500
Blue light (photodynamic) TURBT £7,500–£12,000
Re-resection TURBT (six-week check) £4,500–£7,500
Single-shot mitomycin C (added to TURBT) £600–£900
BCG induction course (6 weeks) £3,500–£5,500
Flexible cystoscopy follow-up £450–£750

Prices vary by hospital, by the urologist and by whether blue light and single-shot chemotherapy are used. Histology and follow-up cystoscopy are itemised separately.

The problem

The complete resection, the muscle in the specimen, and the single-shot chemo.

TURBT is where UK urology quality varies the most. Muscle missed, single-shot chemo skipped, blue light unused. We insist on all three where indicated.

  • Did the specimen include muscle?

    Without detrusor muscle in the specimen, T1 tumours are understaged and treatment goes wrong. Muscle is the standard, not the bonus.

  • Was single-shot chemotherapy given?

  • Was blue light used where needed?

    For high-grade or recurrent disease, blue light finds the tumours white light misses. Not all UK units have it; we use ones that do.

When it helps

When TURBT is the right step.

The situations we see most, plus the one finding that changes the whole plan - muscle invasion means cystectomy or chemo-radiotherapy, not more TURBT.

  • Visible haematuria

    Blood in the urine, any age, needs same-week urology - the commonest presentation of bladder tumour.

  • Bladder mass on imaging

    A lesion on CT urogram or ultrasound in someone with symptoms needs a tissue diagnosis by TURBT.

  • Suspicious cystoscopy finding

    A papillary lesion or a red flat patch seen on flexible cystoscopy is resected and biopsied under GA.

  • Recurrent non-muscle-invasive cancer

    A tumour picked up on surveillance cystoscopy - resected, restaged and re-planned.

  • Persistent microscopic haematuria + risk

    Persistent non-visible haematuria with smoking history or occupational exposure - fully investigated including cystoscopy.

  • Positive urine cytology

    High-grade cells on cytology with a normal white-light scope means blue light TURBT and mapping biopsies.

  • Solitary papillary tumour

    Small, low-grade papillary tumours - often removed with a single, well-mapped TURBT plus single-shot chemotherapy.

  • Red flag: muscle-invasive on staging

    Muscle invasion on TURBT changes the whole pathway - same-week urology MDT for radical cystectomy or bladder preservation, not routine surveillance.

Procedure options

Light, loop, and how you deliver the chemotherapy.

What each option involves - the resection technique, the imaging light used, and how the single-shot chemotherapy is delivered right after.

  • Standard white-light TURBT

    The workhorse. Rigid scope, saline or bipolar loop resection, muscle sampling and single-shot chemotherapy where eligible.

  • Blue light (photodynamic) TURBT

    Hexvix instilled beforehand highlights carcinoma in situ and small lesions missed under white light - first choice for high-risk or high-grade disease.

  • Narrow-band imaging TURBT

    Uses filtered light to enhance vasculature and pick up subtle lesions where blue light is not available.

  • En-bloc resection

    The tumour taken out in a single specimen (loop or laser) rather than piecemeal - easier staging in the right lesion.

  • Re-TURBT at six weeks

    Standard for T1 disease, high-grade tumours without muscle in the specimen, or incomplete first resection.

  • Single-shot intravesical chemotherapy

  • Adjuvant BCG or mitomycin course

    For intermediate- and high-risk non-muscle-invasive disease, given weekly for six weeks with maintenance for high-risk.

  • When TURBT is not enough

    Muscle-invasive disease needs radical cystectomy, chemo-radiotherapy or a bladder-preservation MDT decision - covered on our bladder cancer page.

Safety and recovery

What to expect afterwards - honestly.

TURBT is well established but not trivial - catheter care, single-shot chemo timing and the six-week re-look all deserve a proper plan.

  • Spinal or GA, always with catheter cover

    Spinal keeps you awake and comfortable. GA is used for larger tumours or where mapping biopsies are extensive. A catheter goes in either way.

  • Bladder perforation

    Small extraperitoneal perforations happen in around 1–2% and settle with catheter drainage. True intraperitoneal perforation is rare and needs surgical repair.

  • Bleeding and clot retention

    Some pink urine for a few days is normal. Heavy bleeding or clot blocking the catheter needs the same-day team - bladder washouts on the ward.

  • Urinary tract infection

    UTI rates 5–10% after TURBT. Prophylactic antibiotic covers the peri-operative period.

  • Urethral stricture

    A late narrowing of the urethra, more common with repeated procedures - treatable with dilation or a small endoscopic procedure.

  • Understaging without detrusor muscle

    A resection without muscle in the specimen understages the tumour - hence the six-week re-TURBT rule for T1 or high-grade disease.

  • Recurrence is the norm, not the exception

    Non-muscle-invasive bladder cancer recurs in 50–70% of patients within five years - surveillance cystoscopy is not optional.

  • BCG side effects

    Fever, cystitis, malaise and rarely BCG sepsis - patients need to know when to call and when to go to A&E.

  • Red flags after TURBT

    Fever above 38°C, heavy clots you can’t pass, inability to pass urine after catheter removal, or spreading redness at the drip site need same-day review.

Reading your notes

Your notes in four parts. Read the last one first.

Whether the resection was done under white or blue light, the note the urologist writes keeps to the same shape.

  1. 01 Header

    Findings and tumour map

    Number, size and location of tumours, whether they looked papillary or flat, and where any carcinoma in situ was seen under blue light.

  2. 02 Technique

    Extent of resection and muscle

    Whether the resection was complete, whether detrusor muscle was included, and where separate biopsies were sent.

  3. 03 Findings

    Histology and stage

    The pathologist’s report - stage (Ta, T1, T2), grade, presence of CIS and whether muscle is present - defines the next step.

  4. 04 Impression

    Treatment plan and surveillance

    Read this first: BCG, mitomycin course, re-TURBT, radical treatment, and your check cystoscopy dates.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

TURBT is usually covered when clinically indicated. Adjuvant BCG or mitomycin courses may need separate pre-authorisation.

Frequently asked

Everything we get asked about TURBT.

Quick answers on approach, recovery, cost and long-term outcome.

  • What is a TURBT?

    Trans-urethral resection of bladder tumour is an endoscopic operation done through the urethra to remove a bladder tumour and take enough tissue to work out what type and stage it is. It is the standard first step for any suspicious bladder lesion - diagnostic, staging and, for many small tumours, curative in one procedure.

  • Will I need more than one TURBT?

    Often, yes. A six-week re-TURBT is standard for T1 tumours, for high-grade disease and whenever detrusor muscle was not in the first specimen. Non-muscle-invasive bladder cancer also recurs in 50–70% of patients within five years, so surveillance cystoscopies are set out on the discharge letter.

  • What is blue light cystoscopy?

    A dye called hexaminolevulinate (Hexvix) is instilled into the bladder before the operation. Tumour cells take it up and glow pink under blue light, making carcinoma in situ and small papillary lesions much easier to see and remove. It is the first choice for high-risk, high-grade or recurrent disease.

  • How long is recovery from TURBT?

    Home the same day or after one night. A catheter for 24–48 hours. Pink urine for a few days. Back to office work in a week; no heavy exercise, straining or penetrative sex for two to three weeks.

  • How much does a private TURBT cost in the UK?

    Roughly £4,500–£7,500 as a day-case, £5,500–£9,500 with one night, and £7,500–£12,000 for blue-light TURBT. Single-shot mitomycin adds £600–£900. BCG induction course £3,500–£5,500.

  • What if the tumour has invaded the muscle?

    Muscle-invasive bladder cancer needs a different pathway - radical cystectomy with urinary diversion, or chemo-radiotherapy for bladder preservation. TURBT tells us it is muscle-invasive, and the MDT decides on the best next step within a week.